Gene therapy

US5399346A · kind A · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• W. French Anderson · Bethesda, US
• R. Michael Blaese · Rockville, US
• Steven A. Rosenberg · Potomac, US

Key dates

• Filing date: Mar 30, 1994
• Grant date: Mar 21, 1995
• Expiry date: Mar 30, 2014

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2239/38
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Primary human cells which are genetically engineered with DNA (RNA) encoding a marker or therapeutic which is expressed to be expressed in vivo. Such engineered cells may be used in gene therapy.